A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin

PURPOSE: Opioid therapy for managing chronic pain remains a challenge, as providers must weigh the medical benefit to the patient with the risk of adverse events. Manipulation of many extended-release (ER) opioid formulations may lead to increased serious medical outcomes or death. The economic burd...

Descripción completa

Detalles Bibliográficos
Autores principales: Olatoke, Oluwadara, Zah, Vladimir, Stanicic, Filip, Vukicevic, Djurdja, Yfantopoulos, Platonas, Thompson, Christy, DeGeorge, Michael K, Passik, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901186/
https://www.ncbi.nlm.nih.gov/pubmed/35264862
http://dx.doi.org/10.2147/CEOR.S340290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901186/
https://www.ncbi.nlm.nih.gov/pubmed/35264862
http://dx.doi.org/10.2147/CEOR.S340290

Ejemplares similares